GLP-1 and appetite responses to a meal in lean and overweight adolescents following exercise

Obesity

Volumn 16, Issue 1, 2008, Pages 202-204

  Chanoine, Jean Pierre ^a   MacKelvie, Kerry J ^a   Barr, Susan I ^a   Wong, Alfred C K ^a   Meneilly, Graydon S ^a   Elahi, Dariush H ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1;

ADOLESCENT; APPETITE; ARTICLE; BLOOD; BODY MASS; BODY WEIGHT; COMPARATIVE STUDY; EXERCISE; HEALTH SURVEY; HUMAN; MALE; OBESITY; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOPHYSIOLOGY;

ADOLESCENT; APPETITE; BODY MASS INDEX; EXERCISE; GLUCAGON-LIKE PEPTIDE 1; HEALTH SURVEYS; HUMANS; MALE; OBESITY; OVERWEIGHT; PAIN MEASUREMENT; PROSPECTIVE STUDIES; SATIETY RESPONSE; THINNESS;

EID: 39449094621     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2007.39     Document Type: Article

References (16)

1. Meier JJ, Nauck, MA. Glucagon-like peptide 1(GLP-1) in biology and pathology. Diabetes Metab Res Rev 2005;21:91-117.
2. Flint A, Raben A, Astrup A, Holst JJ. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 1998; 101:515-520.
3. Nauck MA, El-Ouaghlidi A, Gabrys B et al. Secretion of incretin hormones (GIP and QLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes. Regul Pept 2004;122:209-217.
4. Tomasik PJ, Sztefko K, Malek A. GLP-1 as a satiety factor in children with eating disorders. Horm Metab Res 2002;34:77-80.
5. Mackelvie KJ, Meneilly GS, Elahi D et al. Regulation of appetite in lean and obese adolescents after exercise: role of acylated and desacyl ghrelin. J Clin Endocrinol Metab 2007;92:648-654.
6. Meneilly GS, Mcintosh CH, Pederson RA et al. Effect of glucagon-like peptide 1 (7-36 amide) on insulin-mediated glucose uptake in patients with type 1 diabetes. Diabetes Care 2003;26:837-842.
7. Stunkard AJ, Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 1985;29:71-83.
8. Flint A, Raben A, Blundell JE, Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord 2000;24:38-48.
9. Fukase N, Igarashi M, Takahashi H et al. Hypersecretion of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide in obese patients. Diabet Med 1993;10:44-49.
10. Vilsboll T, Krarup T, Sonne J et al. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab 2003;88:2706-2713.
11. Ranganath LR, Beety JM, Morgan LM et al. Attenuated GLP-1 secretion in obesity: cause or consequence? Gut 1996;38:916-919.
12. Brubaker PL, Drucker DJ. Minireview: glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology 2004;145:2653-2659.
13. Gutzwiller JP, Drewe J, Goke B et al. Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. Am J Physiol 1999;276:R1541-R1544.
14. Gutzwiller JP, Goke B, Drewe J et al. Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut 1999;44:81-86.
15. Verdich C, Flint A, Gutzwiller JP et al. A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab 2001;86:4382-4389.
16. Turton MD, O'Shea D, Gunn I et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 1996;379:69-72.